Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1546 AL 1560

[Amyloid-selective Photooxygenation toward Treatment for Amyloid Diseases]

Taniguchi A.

Yakugaku Zasshi. 2018;138(1):47-53. doi: 10.1248/yakushi.17-00186-2.

Therapeutic role of rifampicin in Alzheimer's disease

Yulug B, Hanoglu L, Ozansoy M, Isık D, Kilic U, Kilic E, Schabitz WR.

Psychiatry Clin Neurosci. 2018 Mar;72(3):152-159. doi: 10.1111/pcn.12637. Epub 2018 Feb 10.

Iridoids and Other Monoterpenes in the Alzheimer's Brain: Recent Development and Future Prospects

Habtemariam S.

Molecules. 2018 Jan 7;23(1):117. doi: 10.3390/molecules23010117.

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials

Atri A, Frölich L, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Windfeld K, Raket LL, Cummings JL.

JAMA. 2018 Jan 9;319(2):130-142. doi: 10.1001/jama.2017.20373.

(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease

Becker RE, Greig NH, Lahiri DK, Bledsoe J, Majercik S, Ballard C, Aarsland D, Schneider LS, Flanagan D, Govindarajan R, Sano M, Ferrucci L, Kapogiannis D.

Curr Alzheimer Res. 2018;15(9):883-891. doi: 10.2174/1567205015666180110120026.

Similar treatment outcomes with Ginkgo biloba extract EGb 761 and donepezil in Alzheimer's dementia in very old age: A retrospective observational study

Rapp M, Burkart M, Kohlmann T, Bohlken J.

Int J Clin Pharmacol Ther. 2018 Mar;56(3):130-133. doi: 10.5414/CP203103.

News on the journal Neurological Sciences in 2017

Di Donato I, Federico A.

Neurol Sci. 2018 Jan;39(1):15-21. doi: 10.1007/s10072-017-3241-x.

Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease

Reddy PH, Manczak M, Yin X, Grady MC, Mitchell A, Tonk S, Kuruva CS, Bhatti JS, Kandimalla R, Vijayan M, Kumar S, Wang R, Pradeepkiran JA, Ogunmokun G, Thamarai K, Quesada K, Boles A, Reddy AP.

J Alzheimers Dis. 2018;61(3):843-866. doi: 10.3233/JAD-170512.

Multi-Target Directed Drugs as a Modern Approach for Drug Design Towards Alzheimer's Disease: An Update

de Freitas Silva M, Dias KST, Gontijo VS, Ortiz CJC, Viegas C Jr.

Curr Med Chem. 2018;25(29):3491-3525. doi: 10.2174/0929867325666180111101843.

Cultural Competency in Dementia Care: An African American Case Study

Clark JL, Phoenix S, Bilbrey AC, McManis T, Escal KA, Arulanantham R, Sisay T, Ghatak R.

Clin Gerontol. 2018 May-Jun;41(3):255-260. doi: 10.1080/07317115.2017.1420725. Epub 2018 Jan 17.

The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial

Scherer RW, Drye L, Mintzer J, Lanctôt K, Rosenberg P, Herrmann N, Padala P, Brawman-Mintzer O, Burke W, Craft S, Lerner AJ, Levey A, Porsteinsson A, van Dyck CH; ADMET 2 Research Group.

Trials. 2018 Jan 18;19(1):46. doi: 10.1186/s13063-017-2406-5.

Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer's disease

Karthivashan G, Ganesan P, Park SY, Kim JS, Choi DK.

Drug Deliv. 2018 Nov;25(1):307-320. doi: 10.1080/10717544.2018.1428243.

Emergency Department Use by Community-Dwelling Individuals With Dementia in the United States: An Integrative Review

Hunt LJ, Coombs LA, Stephens CE.

J Gerontol Nurs. 2018 Mar 1;44(3):23-30. doi: 10.3928/00989134-20171206-01. Epub 2018 Jan 23.

Developing a dementia-specific preference--based quality of life measure (AD-5D) in Australia: a valuation study protocol

Comans TA, Nguyen KH, Mulhern B, Corlis M, Li L, Welch A, Kurrle SE, Rowen D, Moyle W, Kularatna S, Ratcliffe J.

BMJ Open. 2018 Jan 21;8(1):e018996. doi: 10.1136/bmjopen-2017-018996.

Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer's disease hallmarks

Reinhardt S, Stoye N, Luderer M, Kiefer F, Schmitt U, Lieb K, Endres K.

Sci Rep. 2018 Jan 22;8(1):1329. doi: 10.1038/s41598-018-19577-7.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias